Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma.

Paoluzzi, Luca

Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jan 2010 - 554-65 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1557-3265

10.1158/1078-0432.CCR-09-1937 doi


Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Apoptosis--drug effects
Boronic Acids--administration & dosage
Bortezomib
Cell Line, Tumor
Cell Survival--drug effects
Depsipeptides--administration & dosage
Dose-Response Relationship, Drug
Drug Synergism
Humans
Hydroxamic Acids--administration & dosage
Lymphoma, Mantle-Cell--drug therapy
Mice
Pyrazines--administration & dosage
Sulfonamides
Xenograft Model Antitumor Assays